Agenda
The following agenda is for the 2027 Indy Hematology Review event.
Saturday, March 13th, 2027
| Time | Event/Topic |
|---|---|
| 6:00 AM - 6:45 AM | Registration |
| 6:45 AM - 7:25 AM | Breakfast Product Theater |
Precursory Events
Session 1
| Time | Event/Topic |
|---|---|
| 7:30 AM - 8:00 AM | State of the Art: 2027: Emerging Therapies in Hematologic Malignancies Ruemu E. Birhiray, MD Professor of Medicine Marian University - Wood College of Osteopathic Medicine |
| 8:00 AM - 8:20 AM | Updating our Armamentarium: Emerging Treatment Options for Newly Diagnosed Patients with AML and Myelodysplastic Syndromes Guillermo Garcia-Manero, MD Chair Ad Interim of the Department of Leukemia in the Division of Cancer Medicine The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 8:20 AM - 8:40 AM | Approaches to the Application of therapeutic Advances to the relapsed Patient with AML and Myelodysplastic Syndromes Rami Komrokji, MD Vice chair of the Malignant Hematology Department Moffitt Cancer Center |
| 8:40 AM - 9:00 AM | Coming Soon |
| 9:00 AM - 9:30 AM | Acute Leukemias: Panel Discussion |
| 9:30 AM - 9:45 AM | Coffee Break - Exhibit Hall |
| 10:05 AM - 10:25 AM | Management of Relapsed Multiple Myeloma Patients: When and How to Apply Novel Therapeutic Tools Saad Usmani, MD, MBA, FACP, FRCP Chief of Myeloma Service Memorial Sloan Kettering Cancer Center |
| 10:25 AM - 10:45 AM | Advancing Care: Treating Waldenstrom’s Macroglobulinemia in Today’s Patients Steven P. Treon, MD, MA, PhD, FRCP, FACP Professor of Medicine Harvard Medical School |
| 10:45 Am - 11:05 AM | Amyloidosis and Other Vexing Plasma Cell Neoplasms Morie Gertz, MD, MACP Chair Emeritus Department of Medicine Mayo Clinic |
| 11:05 AM - 11:25 AM | Coming Soon |
| 11:25 AM - 11:45 AM | Plasma Cell Neoplasms: Panel Discussion |
| 11:45 AM - 12:05 PM | Coming Soon |
| 12:05 PM - 12:25 PM | Modern Approaches to Classical Hematology: Navigating Bleeding and Clotting Disorders Craig Kessler, MD, MACP Professor of Medicine and Pathology Georgetown University Medical Center |
| 12:25 PM - 12:45 PM | Updating the Management of Rare Myeloid and Mast Cell Neoplasms Naveen Pemmaraju, MD Professor of Medicine MD Anderson Cancer Center |
| 12:45 PM - 12:55 PM | Hematology: Panel Discussion |
| 12:55 PM - 1:05 PM | Coffee Break - Exhibit Hall |
| 1:05 PM - 1:45 PM | Lunch and Product Theaters |
| 1:45 PM - 1:55 PM | Coffee Break - Exhibit Hall |
Session Chair: Ruemu E. Birhiray, MD
Session 2
Session Chair: Michael Wiemann, MD, FACP
| Time | Event/Topic |
|---|---|
| 1:55 PM - 2:00 PM | Name Sponsor Introduction |
| 2:00 PM - 2:40 PM | T. Howard Lee Keynote Lecture When You Can Tell Tomorrow: Prognostification and Predicting Outcomes of Myeloid Neoplasms Ayalew Teffari, MD Professor of Medicine Mayo Clinic |
| 2:40 PM - 3:00 PM | Steven Coutré Memorial Lecture in Hematology Innovation Coming Soon |
| 3:00 PM- 3:05 PM | Distinguished Lecturer Series - Panel Discussion |
| 3:05 PM - 3:25 PM | CML in 2026: Advancements and Best Practices in Management Richard Larson, MD Director of Hematologic Malignancies Program University of Chicago Medicine |
| 3:25 PM- 3:45 PM | Coming Soon |
| 3:45 PM- 4:10 PM | Applying Emerging Data: My Current Strategies for Managing Relapsed Chronic Lymphocytic Leukemia Jennifer Woyach, MD Professor in the College of Medicine The Ohio State University School of Medicine |
| 4:10 PM- 4:15 PM | Chronic Leukemias - Panel Discussion |
| 4:15 PM - 4:25 PM | Coffee Break - Exhibit Hall |
| 4:25 PM - 4:45 PM | Emerging Strategies in the Treatment of Aggressive B and T Cell Lymphoma John P. Leonard, MD Laura and Isaac Perlmutter Professor of Hematology and Medical Oncology Department of Medicine of NYU Grossman School of Medicine |
| 4:45 PM - 5:05 PM | “Primum non nocere” Applying Emerging Strategies for the Treatment of Hodgkin Lymphoma Stephen Ansell, MD, PhD Professor of Medicine Mayo Clinic |
| 5:05 PM- 5:25 PM | Coming Soon |
| 5:25 PM- 5:35 PM | Lymphoid malignancies - Panel Discussion |
| 5:35 PM -5:55 PM | T-cell Redirected Antibody Therapy for Lymphoid Malignancies Tycel Phillips, MD Associate Professor of Medicine City of Hope |
| 5:55 PM - 6:15 PM | Acute Lymphoblastic Leukemia: Navigating Current and Emerging Treatment Strategies Richard Stone, MD Professor of Medicine Harvard Medical School |
| 6:15 PM - 6:35 PM | Revolutionizing Lymphoid Malignancies with Cellular Therapy Matthew Lunning, DO, FACP Interim Chief, UNMC Division of Hematology University of Nebraska Medical Center |
| 6:35 PM- 6:55 PM | Harnessing Immune Effector Therapies in Multiple Myeloma Joselle M. Cook, MBBS Assistant Professor of Medicine Mayo Clinic |
| 6:55 PM - 7:15 PM | Referral Timing for Hematopoietic Transplantation and Cellular Therapies: What Clinicians Need to Know Richard Childs, MD Bethesda, Maryland |
| 7:15 PM - 7:20 PM | Lymphoid Malignancies and Cellular Therapies: - Panel Discussion |
| 7:20 PM - 7:30 PM | Hors D'oeuvres |
| 7:30 PM - 8:30 PM | Hematologic Malignancies Townhall |
| Ruemu E. Birhiray, MD – Chair and Moderator | |
| Morie Gertz, MD, MACP – Plasma Cell Disorders and Amyloidosis | |
| Jennifer Woyach, MD – Chronic Lymphocytic Leukemia | |
| Guillermo Garcia-Manero. MD - Acute Leukemias and Myelodysplastic Syndromes | |
| Richard Childs, MD – Cellular Therapies and Transplantation | |
| Saad Usmani, MD, MBA – Multiple Myeloma | |
| Joselle Cook, MBBS – Multiple Myeloma | |
| Ayalew Tefferi, MD – Myeloproliferative Neoplasms |